Cited by 751Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System

Mackie, K.·2005·Handbook of Experimental Pharmacology

DOI 10.1007/3-540-26573-2_10

Open this paper in CoChat — free account

Abstract

CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compounds. This G protein-coupled receptor has a characteristic distribution in the nervous system: It is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum--a distribution that corresponds to the most prominent behavioral effects of cannabis. In addition, this distribution helps to predict neurological and psychological maladies for which manipulation of the endocannabinoid system might be beneficial. CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses. While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 years, there is still more to learn. Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the determination of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.

Integrity signals

Registry

Crossref · 10.1007/3-540-26573-2_10

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Interneurons of the hippocampus
Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4 · Cited by 3,478
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Self-citation
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citation
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085

Show all 103 references

Research works printed but not linked: 1

Riegal AC, Williams JT, Lupica CR (2003) Cananbionid CB1 receptors inhibit GABA-Bmediated synaptic currents in midbrain dopaminergic neurons. Soc Neurosci Abstr 33:462466

Sorted by citations

Items 601–700 of 751

Prenatal cannabinoid exposure alters excitation-inhibition balance through glutamate and GABA receptor-mediated signaling
Pinky, P. D., Smith, W. D., Wiley, M. T., Bloemer, J., Syropoulou, V., Durdanovic, I., Setti, S. E., Pfitzer, J. C., Perman, S., Chowdhury, K. U., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113196 · Cited by 1
Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders
Couttas, T. A., Hoffmann, A., Jieu, B., Golla, F. R., Shepherd, C. E., Leweke, F. M., & Rohleder, C. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04120-4 · Cited by 1
Psychotomimetic Cannabinoid Hyperlocomotion Involves GSK-3β Signaling at Striatopallidal Neurons in Male Mice
Tomaselli, G., Bellocchio, L., Raux, P., Roullot, V., Busquets-García, A., Lalanne, V., Mariani, Y., Cathala, A., Zanese, M., Cannich, A., et al. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100816 · Cited by 1
Role of the Endocannabinoid System in Anxiety and Stress-Related Disorders
Akirav, I. (2011) · InTech eBooks · doi:10.5772/18405 · Cited by 2
Food Intake and Its Control by Signaling Molecules
Vázquez‐Cuevas, F. G., Aguilar‐Roblero, R. A., Arellanes-Licea, E. D. C., Macotela, Y., Martínez, O. V., Villanueva, I., & Díaz‐Muñoz, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00006-7 · Cited by 1
Hypocretins/Orexins and Addiction: Role in Cannabis Dependence
Flores, Á., Maldonado, R. J., & Berrendero, F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00065-x · Cited by 1
Cross-Sectional study of differences in phenomenology of acute psychosis with or without cannabis
Pal, V. S., Rastogi, P., Chauhan, A., & Niranjan, V. (2017) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2017.i10.02 · Cited by 1
Treatments with cannabinoids and brain development
Schönhofen, P., de Vargas, D. M., Parsons, R. B., & Klamt, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817988-8.00036-1 · Cited by 1
Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology
Dionne, O., Abolghasemi, A., Corbin, F., & Çaku, A. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115962 · Cited by 1
Role of anandamide in Alzheimer's disease
Vera, D. M., & Tambaro, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00014-7 · Cited by 1
Balancing efficacy and safety: The dual impact of antiseizure medications on the developing brain
Oliveira, M. S., Fernandes, R. A., Pinto, L. S. F. D. S., Moreira, F. A., de Castro, O. W., & Santos, V. R. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110400 · Cited by 1
Recreational Drugs Repurposed for Medicinal Use – Cannabis
Armour, M., Sinclair, J., & Adler, H. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009585330.006 · Cited by 1
The endocannabinoid system in autism spectrum disorder
Costello, J. A., & Roche, M. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00018-9 · Cited by 1
Cannabinoid Modulation of Dopaminergic Circuits in Neurodegenerative and Neuropsychiatric Disorders
Matricon, J., & Giuffrida, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_5 · Cited by 1
The Recreational Use of Cannabis
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0007 · Cited by 1
Investigating the Role of the Endocannabinoid System in Early Psychosis
O’Neill, A., & Bhattacharyya, S. (2017) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2017.00009 · Cited by 1
Role of Endocannabinoids in Synaptic Plasticity and Memory ☆
Bura, S. A., Almada, R. C., Lutz, B., Marsicano, G., & Wotjak, C. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.02289-6 · Cited by 1
CANNABIS USE AND REPRODUCTIVE HEALTH: AN INVESTIGATION OF TIME TRENDS AND ADVERSE BIRTH OUTCOMES
Chawla, D. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/j3h7-2b02 · Cited by 1
G protein-coupled receptors in neurodegenerative diseases
Guimarães, T. R., & Thathiah, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00017-9 · Cited by 1
Cannabis and Endocannabinoid System
Amornyotin, S. (2021) · Journal of Addiction Medicine and Therapeutic Science · doi:10.17352/2455-3484.000047 · Cited by 1
Interactions between the endogenous cannabinoid system and the peptides of the Tyr-MIF-1 family modulate heat stress-induced analgesia
Nocheva, H., Tashev, R. E., Bocheva, A. I., Atanasova, D., Dandov, A. D., & Lazarov, N. (2020) · Biomedical Reviews · doi:10.14748/bmr.v31.7708 · Cited by 1
Adolescent neurocognitive development and cannabis use
Tervo‐Clemmens, B., Musket, C. W., Calabro, F. J., & Luna, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817986-4.00046-8 · Cited by 1
Cannabinoid Receptor 1 (CB1)
Rech, G. R., & Narouze, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_7 · Cited by 1
Efeitos da maconha não medicinal no neurodesenvolvimento de adolescentes/jovens
Fernandes, R. G. B. M., de Souza, R. C. A. F., Martins, K. G., Oliveira, C. M., Meneses, D. L., & Vilela, L. (2022) · Revista Neurociências · doi:10.34024/rnc.2022.v30.12773 · Cited by 1
Neuropharmacological Approaches to Modulate Cannabinoid Neurotransmission
Bowen, D., Ramesh, S., DeRuiter, J., Govindarajulu, M., Lowery, P., Moore, T., Agrawal, D. C., & Dhanasekaran, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-8822-5_2 · Cited by 1
Cannabinoids
Harry, G. J. (2022) · Advances in neurotoxicology · doi:10.1016/bs.ant.2022.06.001 · Cited by 2
Cannabis effects on the adolescent brain
Murlanova, K., Hasegawa, Y., Kamiya, A., & Pletnikov, M. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823490-7.00007-1 · Cited by 2
Neurotoxicity and neuroprotection induced by plant-derived cannabinoids
Silva, M. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00071-3 · Cited by 1
Primary somatosensory cortex CB1 and 5‑HT1A receptors interaction in the penicillin model of epilepsy
Erfanparast, A., Tamaddonfard, S., Jafarzadeh-Balagafsheh, P., & Tamaddonfard, E. (2024) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2024-2420 · Cited by 1
Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide (Anandamide) by Cytochrome P450 Enzymes
Snider, N. T. (2009) · Deep Blue (University of Michigan) · Cited by 1
Cannabinoids and the brain: New hopes for new therapies
Fernández‐Ruíz, J., Hernández, M., & García‐Movellán, Y. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch6 · Cited by 1
Investigating the role of the endogenous cannabinoid system in emotional modulation of pain: neurochemical and molecular mechanisms
Olango, W. M. (2012) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17506 · Cited by 1
Medical Uses of Marijuana—Fact or Fantasy?
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0005 · Cited by 1
Efeitos do canabidiol no comportamento agressivo induzido por isolamento social em camundongos
dos Santos, A. H. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-20072016-151736 · Cited by 1
Dinner for Two: Digging into how Ghrelin and Endocannabinoid Systems Interact in the Ventral Tegmental Area to Regulate Non-Homeostatic Feeding
Edwards, A. (2020) · doi:10.22215/etd/2020-14020 · Cited by 1
Cannabis
Yanar, A. K., & Yazıcı, Z. C. (2023) · Wiley eBooks · doi:10.1002/9781119983347.ch15 · Cited by 1
Examining Neuropsychological Sex Differences in Young Adult Cannabis Users
Crane, N. A. (2013) · Figshare
The Effects of Cannabinoids on Immune Cells, Responses and Diseases
Constantinescu, C. S., & Tănăsescu, R. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0888-8_11
The cellular processing of the endocannabinoid anandamide and its pharmacological manipulation
Thors, L. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Participação do sistema canabinoide em processos oxidativo e inflamatório relacionados à neurodegeneração in vitro.
da Silva, H. B. (2014) · doi:10.11606/t.42.2014.tde-11032015-134512
Design, Synthesis and Biological Evaluation of novel cannabinoid antagonists
Verma, A. (2012)
Kannabisaren terapiarako erabilera mugimenduaren asalduretan
Morera‐Herreras, T., Miguélez, C., Aristieta, A., Ruíz-Ortega, J. Á., & Torrecilla, M. (2013) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.11048
TRPV1 in Neuropathic Pain and Neurological and Neuropsychiatric Disorders
Palazzo, E., Starowicz, K., Maione, S., & Marzo, V. D. (2010) · Wiley eBooks · doi:10.1002/9780470588284.ch10
Lack of Effect of Lamotrigine on Opioid, Serotonin Type 3 and Cannabinoid Type 1 Receptors in Two Mice Models of Pain
Reda, H. M., Zaitone, S. A., & Moustafa, Y. M. (2014) · Journal of Physiology and Pharmacology Advances · doi:10.5455/jppa.20141116104755
Hirnstrukturelle Veränderungen bei schizophren Ersterkrankten – der Einfluss von Cannabis und familiärer Belastung
Malchow, B. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4033
Synthetic Cannabinoid Can Do Voiding Dysfunction: Reporting of three cases
Bayar, G., Acinikli, H., Çakmak, S., Kireçç, S. L., & Dalkılınç, A. (2014) · Asian Pacific Journal of Health Sciences · doi:10.21276/apjhs.2014.1.4.26
Participação do sistema canabinoide em processos oxidativo e inflamatório relacionados à neurodegeneração in vitro
Humana, F. (2014)
NEURONAL ADAPTATIONS IN THE NUCLEUS ACCUMBENS CORE UNDER ACUTE AND CHRONIC EXPOSURE TO CANNABINOIDS
Lee, S. H. (2015) · IUScholarWorks (Indiana University)
Syntheses and Evaluation of Novel Cannabinoid Type 2 Receptors Tracers for PET Imaging
Slavik, R. (2015) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010349745
Subjecffve effects of cannabidiol in anxiety disorder and canabinoid excretion in chronic daily cannabis smokers during sustained abstinence
Bergamaschi, M. M. (2012) · doi:10.11606/t.60.2012.tde-11012013-102122
Changes of CB1 cannabinoid receptor distribution in temporal lobe epilepsy
Karlócai, M. R. (2012) · Semmelweis University Repository (Semmelweis University) · doi:10.14753/se.2013.1784
Is Cannabis Safe?
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0006
Bioactivity of Medicinal Plants: Progress and Perspectives
Ríos, P. J.-L., & Sendra, R. A. (2009)
Cannabimimetics: The Pharmacological Potential of Cannabinoid Receptor Ligands
Gertsch, J. (2009) · Science Publishers eBooks
Effects of LTD-blocking Tat-GluR2 Peptide on Contextual Fear Memory Impairments Induced by Cannabinoids
Kamino, D. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-5930
Drug therapies to manage nausea and vomiting
Rees, S. (2018) · Nurse Prescribing · doi:10.12968/npre.2018.16.1.37
History and the Plant
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0001
Peripheral and Central Effects of THC
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0003
Retrograde Synaptic Transmitter of Endocannabinoid System - A Neuromodulatory Pathway
Rajajeyakumar, M. (2019) · Neurology & Neurotherapy Open Access Journal · doi:10.23880/nnoaj-16000131
Cannabis and Medicinal Properties.
Madras, B. K. (2016) · PubMed
The regulation of orexin receptor function by dynein light chains
Bélanger-Nelson, E. (2011) · eScholarship@McGill (McGill) · doi:10.82308/12051
Youth Becoming Addict of Cannabis and its Advancement at the Cost of Health
(2019) · ARC Journal of Forensic Science · doi:10.20431/2456-0049.0401002
Changes in the Endocannabinoid system in the Brain Following Bilateral Vestibular Damage
Baek, J. (2011) · Otago University Research Archive (University of Otago)
The innate defensive behaviour and unconditioned fear-induced antinociception evoked by NMDA receptor activation in the medial hypothalamus are modulated by the intradiencephalic treatment with cannabidiol: the role of CB1 cannabinoid receptor
Khan, A. U. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-29042019-162811
Impact of FAAH Genotype and Marijuana Use on Brain Structure and Neuropsychological Performance in Emerging Adults
Shollenbarger, S. G. (2014) · UWM Digital Commons (University of Wisconsin–Milwaukee)
Targeting the cannabinoid and mu opioid receptors with heterodimerized and allosteric ligands
Dvorácskó, S. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10162
The effects of cannabinoid derivatives on pancreatic cancer
Sharafi, G. (2019) · Minerva Access (University of Melbourne)
Cannabinoids in Neurologic Conditions
Gaston, T. E., Szaflarski, J. P., Bowling, A. C., Liu, Y., Seawalt, T., Leehey, M. A., Nelson, E. L., Rajpal, S., Villavicencio, A. T., Bauer, A. M., et al. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_10
Investigation of Safety and Tolerability of ASP3652 Based on Clinical Studies of Cerebrospinal Fluid Transfer After Multiple Doses and Exposure After Single Doses at High Dose Levels
Takizawa, M., Cerneus, D. P., Michon, I. N., Rijnders, S., Meijer, J., Someya, A., & Sato, Y. Z. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01451-6
Evaluation of the Expression Levels of Cannabinoid Type-1 (CB1) Receptor and Phosphorylated Extracellular Signal-Regulated Kinase (p-ERK) in GliomasPreprint
Choucair, N., Sakr, Z., Eddine, H. K., Zaarour, M., Harati, H., Fares, Y., Bahmad, H. F., & Nabha, S. M. (2021) · Research Square · doi:10.21203/rs.3.rs-139114/v1
Biomarkers of Agitation in Patients with Alzheimer's disease
Ruthirakuhan, M. T. (2019) · TSpace (University of Toronto)
The Endogenous Cannabinoid and the Nitricoxidergic Systems Differently Influence Heat and Cold Stress-Induced Analgesia
Nocheva, H., Sabit, Z., & Grigorov, E. E. (2021) · Acta Medica Bulgarica · doi:10.2478/amb-2021-0005
Low‐Frequency Stimulation Prevents Kindling‐Induced Impairment through the Activation of the Endocannabinoid System
Khajei, S., Esmaeilpour, K., Mirnajafi‐Zadeh, J., Sheibani, V., Rezakhani, S., & Masoumi‐Ardakani, Y. (2021) · BioMed Research International · doi:10.1155/2021/5526780
Genetic Variation and Sex Mediate Differential Responses to ∆-9-tetrahydrocannabinol among Inbred Mice
Parks, C. (2020) · doi:10.21007/etd.cghs.2020.0516
État de l’art et intérêt des dosages plasmatiques des substances endocannabinoïdes et endocannabinoïdes-like
Gish, A., Wiart, J., Turpin, É., Allorge, D., & Gaulier, J. (2021) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2021.07.004
Opioid Reinforcement: What It Is And How It Can Be Modulated By Cannabinoids
Cadoni, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_98-1
To be or not to be?
Liang, J. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1112
Investigating the Role of G-protein Bias in the Anti-Nociceptive and Side Effect Profiles of Two Novel Mu Opioid Receptor Agonists Kurkinol and Kurkinorin
Alder, A. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.14245730.v1
The Endocannabinoids
JAMES, S. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108583336.004
Endocannabinoids
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0004
Faculty Opinions recommendation of Dissociation of the pharmacological effects of THC by mTOR blockade.
Nichols, D. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717988247.793472521
Investigating the Role of G-protein Bias in the Anti-Nociceptive and Side Effect Profiles of Two Novel Mu Opioid Receptor Agonists Kurkinol and Kurkinorin
Alder, A. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.14245730
Effects of Simultaneous Reinforcement of Endocannabinoid and Cholinergic Systems on Anxiety-Like Behavior in MicePreprint
Shahidi, ‬., Dindar, A., Komaki‬, A., & Sadeghian, R. (2021) · Research Square · doi:10.21203/rs.3.rs-422248/v1
Behavioral Phenotyping From deleted CB1 Receptors on Cholinergic Neuron TerminalsPreprint
Wu, S., Tsutsui, K., & Fitoussi, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.06.495026
Cannabimimetics
Gertsch, J. (2009) · Science Publishers eBooks · doi:10.1201/b10200-12
WIN-55,212-2-Therapie in einem Modell für die sporadische Alzheimer Erkrankung
Ott, F. W. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9572
Opioid Reinforcement: What It Is and How It Can Be Modulated by Cannabinoids
Cadoni, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_98
Resultados preclínicos de cannabinoides y dolor (algunos)
García, C. G., González, M. S., Martínez‐García, M. Á., Serrano, D. P., & Sánchez-Robles, E. (2022) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2022.4033/2022
Anandamide increases the physical activity of adult zebrafish (Danio rerio)
Smith, J., Shaffer, A., Moeller, E., & Klingerman, C. M. (2023) · BIOS · doi:10.1893/bios-d-20-00004
Functional profile of synthetic cannabinoid receptor agonists: Exploring cannabinoid and noncannabinoid targets
Sachdev, S., Santiago, M., & Bladen, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00046-5
The endocannabinoid system: Signaling and social motivation
Cysneiros, R. M., & Ribeiro, F. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00012-7 · Cited by 1
Distribution of the endocannabinoid system: Linking signaling and development
Dvořáková, M., & Kalinovsky, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00005-x
Alteration of the DSI of CA1 pyramidal neurons at the presence of pilocarpine and on the lithium-pilocarpine model of epilepsy
Moradi, M. (2023) · doi:10.11606/t.17.2023.tde-08052023-142423
Estudio de los efectos del URB597 en un modelo preclínico de la enfermedad de Huntington en ratas
Portillo, G. A. (2019) · doi:10.24275/uami.cz30ps70h
Study of effects of newly synthesised nociceptin analogues on the endocannabinoid system and pain after chronic immobilization stress
Himcheva, I., Stavreva, G., Naydenova, E. D., & Bocheva, A. I. (2023) · Journal of Chemical Technology and Metallurgy · doi:10.59957/jctm.v58i3.90
Interactions Between Anesthetic Agents and Cannabis
Lui, S., & Fielding, A. F. (2024) · Acta Scientific Dental Scienecs · doi:10.31080/asds.2024.08.1797
Review, Analyse und Kausalitätsprüfung von Cannabis-based Medicine und Palmitoylethanolamid als Analgetika bei Rheumaschmerzen
von Bonin, E. (2024) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.83604
Orexin and cannabinoid systems modulate long-term potentiation of the hippocampus CA1 area in anesthetized rats.
Fartootzadeh, R., Taheri, R. A., Nourani, M. R., & Goudarzi, K. (2024) · PubMed Central · doi:10.22038/ijbms.2023.73979.16075
Prenatal Exposure to Cannabinoids Decreases the Expression of Polysialylated-Neural Cell Adhesion Molecule (PSA-NCAM)
Reed, M. N. (2024) · Significances of Bioengineering & Biosciences · doi:10.31031/sbb.2024.06.000650
Copyright Page
Iversen, L. L. (2019) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.002.0003

Authors: Mackie, K.
Affiliations: University of Washington (US)
Corresponding author: Mackie, K.
ORCID: Mackie, K.
Venue: Handbook of Experimental Pharmacology
Publisher: Springer-Verlag
Published: 2005-12-23
Issue: 168
Pages: 299-325
DOI: 10.1007/3-540-26573-2_10
OpenAlex: W2149183149
Cited by: 744
References: 103
Citations by year: 2026: 28 · 2025: 38 · 2024: 47 · 2023: 56 · 2022: 59 · 2021: 69 · 2020: 48 · 2019: 52 · 2018: 40 · 2017: 37 · 2016: 33 · 2015: 31 · 2014: 26 · 2013: 27 · 2012: 32
FWCI: 26.30
Type: book chapter
Language: en
Open access: closed
Locations: Springer eBooks (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA00286, DA11322, R01DA011322, K02DA000286)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: CB1 receptor, cannabinoid receptors, endocannabinoid system, delta-9-tetrahydrocannabinol, G protein-coupled receptors, receptor distribution, central nervous system, peripheral nervous system, hippocampus, amygdala, cerebellum, basal ganglia, neurotransmission
MeSH terms: Animals, Autoradiography, Central Nervous System, Humans, Immunohistochemistry, In Situ Hybridization, Peripheral Nervous System, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks